Incerti Carlo 4
4 · Dyne Therapeutics, Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Incerti Carlo
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-02+39,193→ 39,193 totalExercise: $8.69Exp: 2032-03-01→ Common Stock (39,193 underlying)
Footnotes (1)
- [F1]The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025.